Fasudil Hydrochloride clinical trials
Fasudil Hydrochloride is named as an intervention in 2 current clinical trials in our China register. 2 are recruiting patients now. All registered phases are Phase 2. The sponsor with the most trials is Zhejiang Provincial People's Hospital (1). The most-studied condition is Ovarian Cancer.
Where Fasudil Hydrochloride is approved
All regulators →- 3 EU orphan designations, most recently for treatment of amyotrophic lateral sclerosis (20 Jun 2023, positive)
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
How Fasudil Hydrochloride works
All drug targets →- Rho-associated protein kinase inhibitor InhibitorTarget: Rho-associated protein kinase✓ In ChEMBL and the Guide to Pharmacology
- Eye disorderPhase 3
- Macular retinal edemaPhase 2/3
- Retinopathy of prematurityPhase 2/3
- Alzheimer diseasePhase 2
- Amyotrophic lateral sclerosisPhase 2
- AtherosclerosisPhase 2
- Corticobasal syndromePhase 2
- DementiaPhase 2
- HyperlipidemiaPhase 2
- Progressive supranuclear palsyPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL38380, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 5181, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Fasudil Hydrochloride
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Fasudil Hydrochloride
- ATC code
- C04AX32
- ChEMBL
- CHEMBL38380
- DrugBank
- DB08162
- PubChem CID
- 3547
- CAS number
- 103745-39-7
- FDA UNII
- Q0CH43PGXS
- Wikidata
- Q5437132
- Wikipedia
- Fasudil
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Fasudil Hydrochloride
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
NCT06890858 · ClinicalTrials.gov ↗ · Ovarian Cancer
|
Phase 2 | Recruiting | Zhejiang Provincial People's Hospital | China |
|
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
NCT07250542 · ClinicalTrials.gov ↗ · Prostate Cancer
|
Phase 2 | Recruiting | baotai Liang | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Fasudil Hydrochloride
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Zhejiang Provincial People's Hospital | 1 |
| baotai Liang | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 2 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Fasudil Hydrochloride trials
How many clinical trials are testing Fasudil Hydrochloride?
2 current trials in our China register name Fasudil Hydrochloride as a drug or biological intervention, as of the registry sync on 8 November 2026. Completed and withdrawn studies are not counted.
Are Fasudil Hydrochloride trials recruiting patients?
Yes. 2 of the 2 trials are recruiting: 2 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Fasudil Hydrochloride clinical trials?
Zhejiang Provincial People's Hospital (1) and baotai Liang (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Fasudil Hydrochloride works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Fasudil Hydrochloride works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Fasudil Hydrochloride (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 8 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.